Dr. Jose Oberholzer, MD, is an Associate Professor of Surgery, Endocrinology and Diabetes, and Bioengineering at the University of Illinois at Chicago (UIC), the Director of the Islet and Pancreas Transplant Program and the Chief of the Division of Transplantation. He has extensive experience in clinical and experimental islet transplantation, abdominal organ transplantation, as well as advanced hepatobiliary and pancreatic surgery. In type 1 diabetes, islets in the pancreas are destroyed by the body's immune system. Without islets, the body cannot produce insulin. People with type 1 diabetes require several injections of insulin each day.
The Director of the Islet and Pancreas Transplant Program and the Chief of the Division of Transplantation at the University of Illinois at Chicago, Dr. Jose Olberholzer, MD discusses how he and fellow researchers have modified the procedure for islet cell transplantation and achieved insulin independence in diabetes patients.
Health Topics A-Z
Promising Advances for Type 1 Diabetes: Islet Cell Transplant
Guest
: Dr. Jose Oberholzer, MD
From the Show: Staying Well
Summary: University of Illinois at Chicago is one of only a few centers worldwide able to achieve insulin independence in severe type 1 diabetes patients.
Air Date: 11/12/12
Duration: 10
Host: Melanie Cole, MS
Tagged under